Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Qualigen Therapeutics stock
Learn how to easily invest in Qualigen Therapeutics stock.
Qualigen Therapeutics Inc is a biotechnology business based in the US. Qualigen Therapeutics shares (QLGN) are listed on the NASDAQ and all prices are listed in US Dollars. Qualigen Therapeutics employs 39 staff and has a trailing 12-month revenue of around $4.8 million.
How to buy shares in Qualigen Therapeutics
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – QLGN – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Qualigen Therapeutics stock price (NASDAQ: QLGN)Use our graph to track the performance of QLGN stocks over time.
Qualigen Therapeutics shares at a glance
|Latest market close||$0.27|
|52-week range||$0.26 - $3.12|
|50-day moving average||$0.39|
|200-day moving average||$0.63|
|Wall St. target price||$4.75|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-0.55|
Buy Qualigen Therapeutics shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Qualigen Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Qualigen Therapeutics price performance over time
|1 week (2022-09-22)||-4.91%|
|1 month (2022-08-30)||N/A|
|3 months (2022-06-30)||-53.16%|
|6 months (2022-03-30)||N/A|
|1 year (2021-10-01)||-79.30%|
|2 years (2020-10-02)||-94.41%|
|3 years (2019-10-03)||0.2679|
|5 years (2017-10-03)||0.3638|
Qualigen Therapeutics financials
|Revenue TTM||$4.8 million|
|Gross profit TTM||$-4,795,478|
|Return on assets TTM||-35.16%|
|Return on equity TTM||-102.2%|
|Market capitalisation||$11.1 million|
TTM: trailing 12 months
Qualigen Therapeutics share dividends
We're not expecting Qualigen Therapeutics to pay a dividend over the next 12 months.
Have Qualigen Therapeutics's shares ever split?
Qualigen Therapeutics's shares were split on a 1:25 basis on 26 May 2020. So if you had owned 25 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Qualigen Therapeutics shares – just the quantity. However, indirectly, the new 2400% higher share price could have impacted the market appetite for Qualigen Therapeutics shares which in turn could have impacted Qualigen Therapeutics's share price.
Qualigen Therapeutics share price volatility
Over the last 12 months, Qualigen Therapeutics's shares have ranged in value from as little as $0.26 up to $3.12. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Qualigen Therapeutics's is -0.1625. This would suggest that Qualigen Therapeutics's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Qualigen Therapeutics has bucked the trend.
Qualigen Therapeutics overview
Qualigen Therapeutics, Inc. , a biotechnology company, develops novel therapeutic products for the treatment of cancer and infectious diseases. It offers FastPack, a rapid diagnostic testing system. The company is developing QN-302 for the treatment of pancreatic ductal adenocarcinoma; QN-247, a DNA coated gold nanoparticle cancer drug candidate that targets various cancers; RAS-F, a small-molecule RAS oncogene protein-protein inhibitor that blocks RAS mutations and inhibits tumor formation; and STARS blood cleansing system, a DNA/RNA-based treatment device that removes tumor-produced compounds and viruses from a patient's blood. Qualigen Therapeutics, Inc. was founded in 1996 and is based in Carlsbad, California. .
Qualigen Therapeutics in the news
Qualigen Therapeutics Presents Data on QN-302 at AACR’s Pancreatic Cancer Meeting
Frequently asked questionsWhat percentage of Qualigen Therapeutics is owned by insiders or institutions?
Currently 9.825% of Qualigen Therapeutics shares are held by insiders and 6.167% by institutions. How many people work for Qualigen Therapeutics?
Latest data suggests 39 work at Qualigen Therapeutics. When does the fiscal year end for Qualigen Therapeutics?
Qualigen Therapeutics's fiscal year ends in December. Where is Qualigen Therapeutics based?
Qualigen Therapeutics's address is: 2042 Corte Del Nogal, Carlsbad, CA, United States, 92011 What is Qualigen Therapeutics's ISIN number?
Qualigen Therapeutics's international securities identification number is: US74754R1032
More guides on Finder
Alternatives to Webull
Looking for a discount broker like Webull that offers something different? Here are some of the top alternatives to consider.
Best renewable energy stocks for 2022
Here are the best renewable energy stocks that should be on your radar to help you grow your green portfolio
Here are 6 manganese stocks that should be on your radar as EV batteries create new demand.
The best dividend stocks for 2022
Our list of 10 dividend stocks to watch in 2022.
How to buy YanGuFang International Group (YGF) stock when it goes public
Everything we know about the YanGuFang International Group IPO, plus information on how to buy in.
What are the FAANG stocks and how do you invest in them?
Looking to invest in tech? Here’s how to buy shares in the major tech companies, known as FAANG stocks.
How to buy soccer stocks
A simple guide to buying stocks in your favorite European soccer team.
How to buy Juventus stock
Steps to owning and managing JUVE, with 24-hour and historical pricing before you buy.
How to buy AS Roma stock
Steps to owning and managing ASR, with 24-hour and historical pricing before you buy.
How to buy Borussia Dortmund stock
Steps to owning and managing BVB, with 24-hour and historical pricing before you buy.
Ask an Expert